|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Head and Neck Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Head and Neck Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| 4 | Interventions listed in this trial | ||||
| TPF, radiotherapy and cisplatin. | |||||
| TPF, radiotherapy and cetuximab. | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Cetuximab | |||||
| Cisplatin | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Radiation-Sensitizing Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | |||||